| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |